search
Company Information
USD
1.12
- (-6.7%)
NASDAQ:PACB, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Industry: Medical Devices
End of Day: 9 May 2025 GMT-4
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Address

1305 O’Brien Drive

Classification

Sector

Healthcare

Industry Group

Medical Devices & Instruments

Industry

Medical Devices

Key Executives

Mr. Christian O. Henry
CEO/Director/President
Mr. David W. Meline
Director
Ms. Kathy P. Ordonez
Director
Dr. Lucy Shapiro
Director
Mr. Marshall L. Mohr
Director
Mr. Randall S. Livingston
Director
Mr. William W. Ericson
Director
Dr. John F. Milligan, PhD
Chairman of the Board/Director
Ms. Susan G. Kim
CFO
Dr. Hannah A. Valantine, M.D.
Director
Ms. Michele Farmer
Chief Accounting Officer/Vice President
Mr. Mark Van Oene
COO
Mr. Jeff Eidel
Other Executive Officer

Ownership

Institution Holdings

ARK Investment Management LLC
34,504,273 (12.902%)
Vanguard Group Inc
26,789,552 (10.017%)
BlackRock Inc
24,642,666 (9.214%)
Madrone Advisors LLC
17,591,915 (6.578%)
Nikko Asset Management Americas Inc
13,200,375 (4.936%)
Sumitomo Mitsui Trust Holdings Inc
13,200,375 (4.936%)
Morgan Stanley - Brokerage Accounts
11,109,582 (4.154%)
BlackRock Fund Advisors
10,981,377 (4.098%)
Jackson Square Partners, LLC
9,704,766 (3.629%)
Vanguard Investments Australia Ltd
8,646,449 (3.227%)

Funds Holdings

ARK Disruptive Innovation Full Composite
19,557,245 (7.299%)
ARK Innovation ETF
19,090,454 (7.125%)
ARK Genomic Revolution
13,028,654 (4.862%)
ARK Genomic Revolution ETF
11,791,103 (4.400%)
Vanguard Total Stock Market Index Fund
8,595,747 (3.208%)
Vanguard US Total Market Shares ETF
8,595,747 (3.208%)
Nikko AM ARK Positive Change Innovt Fd
7,301,881 (2.725%)
Vanguard Small Cap Index
6,828,551 (2.548%)
iShares Russell 2000 ETF
6,154,243 (2.297%)
Delaware Small Cap Core Fund
5,518,595 (2.060%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices